Fresenius Boosts Forecast, Confirms Plans to Exit Vamed Business [BNN Bloomberg (Canada)]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: BNN Bloomberg
Earnings will probably grow as much as 10% before interest and taxes in 2024, according to a statement Tuesday. That's up from a previous target for as much as 8% growth. Revenue is also expected to rise faster than previously projected, the company said. Since taking over at Fresenius in October 2022, Chief Executive Officer Michael Sen has looked to sharpen the German health-care company's focus after years of complaints from investors that it was too complex. He's prioritizing growth at the Kabi intravenous-drug unit and Helios division, which owns and operates hospitals in Europe and Latin America. Meanwhile, Sen had already been paring back the Vamed division, which houses everything from a hospital project development business to services for nurses. The company announced plans last week to sell a controlling stake in the Vamed rehabilitation business, which includes 67 facilities located in central Europe and the UK. Fresenius said Tuesday that it has started a structure
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Compounding Pharmacy Global Strategic Business Report 2024: Market to Reach $17.7 Billion by 2030 from $13 Billion in 2023 [Yahoo! Finance]Yahoo! Finance
- STRABAG and PORR to acquire parts of VAMED group for €90m [Yahoo! Finance]Yahoo! Finance
- Fresenius Said to Plan Elimination of Vamed in Streamlining Step [BNN Bloomberg (Canada)]BNN Bloomberg
- Fresenius Sells Controlling Stake in Vamed Rehab Business to PAI [BNN Bloomberg (Canada)]BNN Bloomberg
- Institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE) shares but retail investors control 43% of the company [Yahoo! Finance]Yahoo! Finance